Concepedia
Statistics
Publications
91
Citations
9.8K
H-Index
49
Active since
2003
Affiliations
United States Food and Drug Administration(Current)
Center for Drug Evaluation and Research
National Cancer Institute
National Institutes of Health
Center for Cancer Research
Marc R. Theoret is an author at United States Food and Drug Administration specializing in oncology, medicine, and pharmacology.
Publications per year
2003–2025
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
Willem W. Overwijk, Marc R. Theoret, Steven E. Finkelstein et al. · The Journal of Experimental Medicine · 2003 · 918 citations · Full text
Life Sciences, Immunology, Oncology +17
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev Shrimali, Zhiya Yu, Marc R. Theoret et al. · Cancer Research · 2010 · 676 citations · Full text
Medicine, Immunology, Oncology +17
IL-15 enhances the <i>in vivo</i> antitumor activity of tumor-reactive CD8 <sup>+</sup> T Cells
Christopher A. Klebanoff, Steven E. Finkelstein, Deborah R. Surman et al. · Proceedings of the National Academy of Sciences · 2004 · 582 citations · Full text
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 568 citations · Full text
Medicine, Oncology, Pharmacology +17
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 346 citations
1–5 of 91